The ambulatory ECG records the electrical activity of heart while walking (ambulatory) and doing normal activities. In contrast to the usual 12 lead ECG, where the heart’s electrical signals are captured for only a few seconds, the continuous ambulatory ECG monitor can record such signals over a prolonged period at the patient’s own home or work environment.
Ambulatory ECG monitoring, which can be performed using a variety of techniques for as short as 24 to 48 hours and for as long as months to years, offers the opportunity to review cardiac ECG data during normal routine activity, including any physical and psychological stresses. Ambulatory ECG monitoring for longer periods (when compared with standard ECG for a 10-second time period) is more sensitive for detecting spontaneous, often highly variable cardiac arrhythmias or conduction abnormalities. Current ambulatory ECG monitoring technologies include traditional holter, event monitors, mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders.
The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ageing population, increasing health care expenditure, accelerating economic growth, growing burden of atrial fibrillation and rise in prevalence of cardiovascular disorders. The major trends observed in this market include technological advancements, increased demand for home based monitoring systems product innovation- PocketECG. However, the growth of this budding is constrained by challenges such as high competition, stringent regulations and high barriers to entry.
The report “The US Ambulatory ECG Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: BioTelemetry, Inc., Koninklijke Philips N.V, iRhythm Technologies Inc. and Medtronic Plc. are being profiled along with their key financials and strategies for growth.